Back
G1 Therapeutics Stock Price Chart
Sponsored
GTHX
Sponsored
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.16
Seasonality Move:
-14.81%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GTHX is experiencing slight buying pressure.
G1 Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.14 | Buy |
20-day SMA: | 7.13 | Buy |
50-day SMA: | 5.75 | Buy |
200-day SMA: | 4.06 | Buy |
8-day EMA: | 7.14 | Buy |
20-day EMA: | 6.96 | Buy |
50-day EMA: | 6.03 | Buy |
200-day EMA: | 4.37 | Buy |
G1 Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.34 | Buy |
Relative Strength Index (14 RSI): | 84.39 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.1 - 7.14) | Buy |
Bollinger Bands (100): | (2.83 - 6.37) | Buy |
G1 Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for G1 Therapeutics Stock
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 7.15 while GTHX 8-day simple moving average is 7.14, which is a Buy signal.
- The stock price of GTHX is 7.15 while G1 Therapeutics 20-day SMA is 7.13, which makes it a Buy.
- G1 Therapeutics 50-day simple moving average is 5.75 while GTHX share price is 7.15, making it a Buy technically.
- GTHX stock price is 7.15 and G1 Therapeutics 200-day simple moving average is 4.06, creating a Buy signal.
GTHX Technical Analysis vs Fundamental Analysis
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics a Buy or a Sell?
-
G1 Therapeutics stock is rated a Sell
The current G1 Therapeutics [GTHX] share price is $7.15. The Score for GTHX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
G1 Therapeutics Stock Info
Market Cap:
377.22M
Price in USD:
7.15
Share Volume:
0
G1 Therapeutics 52-Week Range
52-Week High:
7.19
52-Week Low:
1.08
Sell
46
G1 Therapeutics (GTHX)
is a Sell
G1 Therapeutics Share Price Forecast
-
What is the G1 Therapeutics stock price today?
The G1 Therapeutics stock price is 7.15 USD today. -
Will GTHX stock go up or go down?
G1 Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is G1 Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, G1 Therapeutics is overvalued.
Is G1 Therapeutics Stock a Buy?
- G1 Therapeutics share price is 7.15 while GTHX 8-day exponential moving average is 7.14, which is a Buy signal.
- The stock price of GTHX is 7.15 while G1 Therapeutics 20-day EMA is 6.96, which makes it a Buy.
- G1 Therapeutics 50-day exponential moving average is 6.03 while GTHX share price is 7.15, making it a Buy technically.
- GTHX stock price is 7.15 and G1 Therapeutics 200-day simple moving average is 4.37, creating a Buy signal.
Fundamental Analysis of G1 Therapeutics
Is G1 Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.08 per share, an increase this year of $0.54 per share, and an increase next year of $0.37 per share.
Technical Analysis of G1 Therapeutics
Should I short G1 Therapeutics stock?
- GTHX Moving Average Covergence Divergence (MACD) indicator is 0.34, suggesting G1 Therapeutics is a Buy
- G1 Therapeutics Relative Strength Index (RSI) is 84.39, which suggest G1 Therapeutics is overbought
- The Bollinger Bands (25) for G1 Therapeutics is (7.1 - 7.14), which suggest G1 Therapeutics is a Buy
- The Bollinger Bands (100) for G1 Therapeutics is (2.83 - 6.37), which suggest G1 Therapeutics is a Buy
* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.